Ticker

Analyst Price Targets — PLUR

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
June 2, 2025 11:04 amMatthew VeneziaIndustrial Alliance Securities$12.00$4.47TheFly Pluri re-initiated with a Buy at Alliance Global Partners

Latest News for PLUR

Pluri Inc. (NASDAQ:PLUR) Sees Large Increase in Short Interest

Pluri Inc. (NASDAQ: PLUR - Get Free Report) was the target of a large increase in short interest during the month of January. As of January 30th, there was short interest totaling 22,147 shares, an increase of 22.7% from the January 15th total of 18,051 shares. Approximately 0.3% of the company's shares are sold short. Based

Defense World • Feb 17, 2026
Pluri and Remedy Cell Expand Collaboration; Successful Engineering Runs and Clinical-Grade Manufacturing Achieved

HAIFA, Israel, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Pluri, Inc. (“Pluri”, the “Company”, “we” or “us”) (Nasdaq, TASE: PLUR), a leading biotechnology company leveraging its proprietary platform for cell-based solutions through a collaborative network of ventures, today announced expansion of its manufacturing agreement signed in 2024 with Remedy Cell Ltd. (“Remedy Cell”), an innovative biopharmaceutical company…

GlobeNewsWire • Dec 22, 2025
Pluri (NASDAQ:PLUR) Stock Price Down 12.7% – Here’s Why

Pluri Inc. (NASDAQ: PLUR - Get Free Report) shares dropped 12.7% during trading on Thursday. The stock traded as low as $3.04 and last traded at $3.09. Approximately 121,244 shares traded hands during trading, an increase of 136% from the average daily volume of 51,287 shares. The stock had previously closed at $3.54. Analyst Ratings

Defense World • Dec 12, 2025

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for PLUR.

No House trades found for PLUR.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top